Comparison of humoral and cellular immune responses in hematologic diseases following completed vaccination protocol with BBIBP-CorV, or AZD1222, or BNT162b2 vaccines against SARS-CoV-2

BACKGROUND: Vaccination has proven the potential to control the COVID-19 pandemic worldwide. Although recent evidence suggests a poor humoral response against SARS-CoV-2 in vaccinated hematological disease (HD) patients, data on vaccination in these patients is limited with the comparison of mRNA-ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Szabó, Enikő, Modok, Szabolcs, Rónaszéki, Benedek, Faragó, Anna, Gémes, Nikolett, Nagy, Lajos I., Hackler, László, Farkas, Katalin, Neuperger, Patrícia, Balog, József Á., Balog, Attila, Puskás, László G., Szebeni, Gabor J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389666/
https://www.ncbi.nlm.nih.gov/pubmed/37529238
http://dx.doi.org/10.3389/fmed.2023.1176168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10389666/
https://www.ncbi.nlm.nih.gov/pubmed/37529238
http://dx.doi.org/10.3389/fmed.2023.1176168

Ejemplares similares